Daratumumab plus Lenalidomide and Dexamethasone for Untreated Myeloma von Facon, Thierry, Kumar, Shaji, Plesner, Torben, Orlowski, Robert Z, Moreau, Philippe, Bahlis, Nizar, Basu, Supratik, Nahi, Hareth, Hulin, Cyrille, Quach, Hang, Goldschmidt, Hartmut, O’Dwyer, Michael, Perrot, Aurore, Venner, Christopher P, Weisel, Katja, Mace, Joseph R, Raje, Noopur, Attal, Michel, Tiab, Mourad, Macro, Margaret, Frenzel, Laurent, Leleu, Xavier, Ahmadi, Tahamtan, Chiu, Christopher, Wang, Jianping, Van Rampelbergh, Rian, Uhlar, Clarissa M, Kobos, Rachel, Qi, Ming, Usmani, Saad Z

Volltext

The use of bisphosphonates in multiple myeloma: recommendations of an expert panel on behalf of the European Myeloma Network von Terpos, E., Sezer, O., Croucher, P.I., García-Sanz, R., Boccadoro, M., San Miguel, J., Ashcroft, J., Bladé, J., Cavo, M., Delforge, M., Dimopoulos, M.-A., Facon, T., Macro, M., Waage, A., Sonneveld, P.

Volltext

Treatment of Older Patients with Mantle-Cell Lymphoma von Kluin-Nelemans, H.C, Hoster, E, Hermine, O, Walewski, J, Trneny, M, Geisler, C.H, Stilgenbauer, S, Thieblemont, C, Vehling-Kaiser, U, Doorduijn, J.K, Coiffier, B, Forstpointner, R, Tilly, H, Kanz, L, Feugier, P, Szymczyk, M, Hallek, M, Kremers, S, Lepeu, G, Sanhes, L, Zijlstra, J.M, Bouabdallah, R, Lugtenburg, P.J, Macro, M, Pfreundschuh, M, Procházka, V, Di Raimondo, F, Ribrag, V, Uppenkamp, M, André, M, Klapper, W, Hiddemann, W, Unterhalt, M, Dreyling, M.H

Volltext

Teclistamab for relapsed refractory multiple myeloma patients on dialysis von Lebreton, P, Lachenal, F, Bouillie, S, Pica, G M, Aftisse, H, Pascal, L, Montes, L, Macro, M, Johnson, N, Harel, S, Fernandez, M, De Renzis, B, Lioure, B, Lazareth, A, Javelot, M, Louni, C, Huart, A, Perrot, A

Volltext

Deletion of the 1p32 region is a major independent prognostic factor in young patients with myeloma: the IFM experience on 1195 patients von Hebraud, B, Leleu, X, Lauwers-Cances, V, Roussel, M, Caillot, D, Marit, G, Karlin, L, Hulin, C, Gentil, C, Guilhot, F, Garderet, L, Lamy, T, Brechignac, S, Pegourie, B, Jaubert, J, Dib, M, Stoppa, A-M, Sebban, C, Fohrer, C, Fontan, J, Fruchart, C, Macro, M, Orsini-Piocelle, F, Lepeu, G, Sohn, C, Corre, J, Facon, T, Moreau, P, Attal, M, Avet-Loiseau, H

Volltext

Real-world effectiveness of ixazomib combined with lenalidomide and dexamethasone in relapsed/refractory multiple myeloma: the REMIX study von Macro, M., Hulin, C., Vincent, L., Charvet-Rumpler, A., Benboubker, L., Calmettes, C., Stoppa, A.-M., Laribi, K., Clement-Filliatre, L., Zerazhi, H., Honeyman, F., Richez, V., Maloisel, F., Karlin, L., Barrak, J., Chouaid, C., Leleu, X.

Volltext

Real-Life Management of Patients Aged 80 Years Old and Over With Multiple Myeloma: Results of the EMMY Cohort von Chalopin, T., Macro, M., Decaux, O., Royer, B., Gounot, R., Bobin, A., Karlin, L., Mohty, M., Frenzel, L., Perrot, A., Manier, S., Vincent, L., Dib, M., Slama, B., Richez, V., Allangba, O., Zunic, P., Newinger-Porte, M., Mariette, C., Joly, B., Gay, J., Botoc, I., Malfuson, JV, Garlantezec, R., Hulin, C.

Volltext

Cytogenetic and therapeutic characterization of primary plasma cell leukemia: the IFM experience von Avet-Loiseau, H, Roussel, M, Campion, L, Leleu, X, Marit, G, Jardel, H, Dib, M, Decaux, O, Lamy, T, Tiab, M, Cony-Makhoul, P, Banos, A, Lepeu, G, Lifermann, F, Macro, M, Kolb, B, Hulin, C, Caillot, D, Traulle, C, Mathiot, C, Royer, B

Volltext

Rituximab salvage therapy in adults with immune thrombocytopenia: retrospective study on efficacy and safety profiles von Reboursiere, Emilie, Fouques, H., Maigne, G., Johnson, H., Chantepie, S., Gac, A. C., Reman, O., Macro, M., Benabed, K., Troussard, X., Damaj, G., Cheze, S.

Volltext

Incidence and risk factors for central nervous system occurrence in elderly patients with diffuse large-B-cell lymphoma: influence of rituximab von Feugier, P., Virion, J. M., Tilly, H., Haioun, C., Marit, G., Macro, M., Bordessoule, D., Recher, C., Blanc, M., Molina, T., Lederlin, P., Coiffier, B.

Volltext

Long‐term analysis of the RiBVD phase II trial reveals the unfavorable impact of TP53 mutations and hypoalbuminemia in elderly mantle cell lymphoma patients. For the LYSA group von Carras, S., Torroja, A., Emadali, A., Daguindau, N., Tempescul, A., Macro, M., Moreau, A., Tchernonog, E., Houot, R., Schmitt, A., Dartigeas, C., Dupuis, J., Jardin, F., Banos, A., Corm, S., Barbieux, S., Zerazhi, H., Arkam, Y., Fouillet, L., Fontan, J., Vilque, J., Moles, M., Sarkozy, C., Morineau, N., Joly, B., Voillat, L., Alexis, M., Fornecker, L. M., Garidi, R., Amorim, S., Bouabdallah, K., Dorvaux, V., Chabrot, C., Feugier, P., Damaj, G., Fleury, J., Delwail, V., Ysebaert, L., Burroni, B., Callanan, M., Legouill, S., Gressin, R.

Volltext

Safe and prolonged survival with long-term exposure to pomalidomide in relapsed/refractory myeloma von Fouquet, G., Pegourie, B., Macro, M., Petillon, M.O., Karlin, L., Caillot, D., Roussel, M., Arnulf, B., Mathiot, C., Marit, G., Kolb, B., Stoppa, A.M., Brechiniac, S., Richez, V., Rodon, P., Banos, A., Wetterwald, M., Garderet, L., Royer, B., Hulin, C., Benbouker, L., Decaux, O., Escoffre-Barbe, M., Fermand, J.P., Attal, M., Avet-Loiseau, H., Moreau, P., Facon, T., Leleu, X.

Volltext

B01 VENETOCLAX TARGETED THERAPY in AL AMYLOIDOSIS PATIENTS: A RETROSPECTIVE ANALYSIS FROM THE FRENCH AMYLOIDOSIS NETWORK von Roussel, M., Pirotte, M., Gounot, R., Queru, K., Rizzo, O., Royer, B., Harel, S., Desport, E., Huart, A., Niault, M., Karlin, L., Decaux, O., Chalopin, T., Carpentier, B., Macro, M., Vignon, M., Chalayer, E., Stoppa, AM, Bridoux, F., Jaccard, A.

Volltext

P09 DARATUMUMAB PLUS LENALIDOMIDE AND DEXAMETHASONE (D‐RD) VERSUS LENALIDOMIDE AND DEXAMETHASONE (RD) ALONE IN TRANSPLANT‐INELIGIBLE PATIENTS WITH NEWLY DIAGNOSED MULTIPLE MYELOMA... von Weisel, K., Kumar, S., Moreau, P., Bahlis, N., Facon, T., Plesner, T., Orlowski, R., Basu, S., Nahi, H., Hulin, C., Quach, H., Goldschmidt, H., O'Dwyer, M., Perrot, A., Venner, C., Raje, N., Tiab, M., Macro, M., Frenzel, L., Leleu, X., Pei, H., Krevvata, M, Carson, R, Borgsten, F., Usmani, S.

Volltext

S176: DARATUMUMAB CARFILZOMIB LENALIDOMIDE AND DEXAMETHASONE AS INDUCTION THERAPY IN HIGH‐RISK TRANSPLANT ELIGIBLE NEWLY DIAGNOSED MYELOMA PATIENTS: RESULTS OF THE PHASE 2 STUDY IF... von Touzeau, C., Perrrot, A., Hulin, C., Manier, S., Macro, M., Chretien, M.‐L., Karlin, L., Decaux, O., Jacquet, C., Tiab, M., Leleu, X., Planchce, L., Avet‐Loiseau, H., Moreau, P.

Volltext

P956: EMMY COHORT: MANAGEMENT OF NEWLY DIAGNOSED OR RELAPSED/ REFRACTORY MULTIPLE MYELOMA IN PATIENTS AGED OF 80 YEARS AND OVER von Macro, M., Decaux, O., Perrot, A., Royer, B., Chretien, M., Belhadj, K., Mohty, M., Frenzel, L., Leleu, X., Dib, M., Allangba, O., Zunic, P., Botoc, I., Malfuson, J., Moreau, P., Garlantazec, R., Texier, N., Germain, R., Deal, C., Hulin, C.

Volltext

P904: CILTACABTAGENE AUTOLEUCEL VS TREATMENTS FROM REAL‐WORLD CLINICAL PRACTICE FOR TRIPLE CLASS EXPOSED PATIENTS WITH MULTIPLE MYELOMA: ADJUSTED COMPARISONS BASED ON CARTITUDE‐1 A... von Decaux, O., Hulin, C., Perrot, A., Macro, M., Frenzel, L., Diels, J., Perualila, N. J., Ghilotti, F., Haefliger, B., Goldsztajn, E., Vernet, S., Thevenon, J., Willaime, M., Texier, N., Schecter, J. M., Madduri, D., Jackson, C., Valluri, S., Moreau, P.

Volltext

P955: CARFILZOMIB IN RELAPSED/REFRACTORY MULTIPLE MYELOMA PATIENTS: THE REAL‐LIFE EXPERIENCE OF EMMY von Hulin, C., Macro, M., Perrot, A., Royer, B., Caillot, D., Belhadj, K., Frenzel, L., Benramdane, R., Demarquette, H., Bareau, B., Darre, S., Calmettes, C., Le Calloch, R., Bouketouche, M., Laribi, K., Texier, N., Willaime, M., Deal, C., Moreau, P., Decaux, O.

Volltext

P925: IMPACT OF PRIOR TREATMENT EXPOSURE ON THE EFFECTIVENESS OF IXAZOMIB‐LENALIDOMIDE‐DEXAMETHASONE IN RELAPSED/REFRACTORY MULTIPLE MYELOMA PATIENTS TREATED IN ROUTINE CLINICAL PR... von Lee, H. C., Ramasamy, K., Macro, M., Davies, F. E., Abonour, R., Rhee, F., Hungria, V. T., Puig, N., Ren, K., Silar, J., Enwemadu, V., Cherepanov, D., Stull, D. M., Leleu, X.

Volltext

P872: DEL(1P32) REMAINS A POWERFUL PROGNOSTIC FACTOR IN A LARGE COHORT OF NDMM PATIENTS: AN UPDATE von Schavgoulidze, A., Perrot, A., Cazaubiel, T., Leleu, X., Manier, S., Buisson, L., Maheo, S., Do Souto Ferreira, L., Lannes, R., Pavageau, L., Hulin, C., Marolleau, J.‐P., Voillat, L., Belhadj, K., Divoux, M., Slama, B., Brechignac, S., Macro, M., Stoppa, A.‐M., Sanhes, L., Orsini‐Piocelle, F., Fontan, J., Chretien, M.‐L., Demarquette, H., Mohty, M., Avet‐Loiseau, H., Corre, J.

Volltext